SCHEMBL23937676

SCHEMBL23937676

CNC(=O)c1cc(N)c2ccn(C)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC2 Q92769 1/20 0.36
RORC P51449 2/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937675 0.83 TUBB4A (0.39) HPGDTSHRHTTSMN1; SMN2HDAC8
SCHEMBL17113154 0.82 USP2 (0.48) HPGDTSHRSMN1; SMN2TUBB4ATUBB
SCHEMBL30317473 0.73 MAPK11 (0.53) HPGDTSHRHTTSMN1; SMN2HDAC8
SCHEMBL8569571 0.70 MAOB (0.60) HPGDTSHRHTTSMN1; SMN2HDAC6
SCHEMBL15910569 0.70 PRKCI (0.41) TSHRSMN1; SMN2KDM4EPRKCI
SCHEMBL23937850 0.69 BAZ2B (0.40) HPGDTSHRTUBB4ATUBBTUBA3C
SCHEMBL25014733 0.69 RET (0.44) PLAUACSS2BRD4PLK1
SCHEMBL15910789 0.68 CSNK2A1 (0.45) HPGDTSHRHTTSMN1; SMN2HDAC8
SCHEMBL940919 0.68 PLAU (0.53) HPGDTSHRHTTSMN1; SMN2HDAC8
SCHEMBL29582662 0.68 PLAU (0.53) HPGDTSHRHTTSMN1; SMN2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed